These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Letter To The Editor - Drug Eruption After Sustained Release Naltrexone Pellet Implantation. Ak S; Can Gürel Ş Turk Psikiyatri Derg; 2020; 31(2):146-147. PubMed ID: 32594504 [No Abstract] [Full Text] [Related]
7. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Grant JE; Kim SW; Odlaug BL Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077 [TBL] [Abstract][Full Text] [Related]
8. Naltrexone-bupropion combination therapy for protracted abstinence dysphoria. Williams J; Ziedonis DM Am J Addict; 2003; 12(3):270-2. PubMed ID: 12851023 [No Abstract] [Full Text] [Related]
9. The effect of naltrexone on sleep parameters in healthy male volunteers. Sramek J; Andry JM; Ding H; Riordan HJ; Leibowitz M; Cutler NR J Clin Psychopharmacol; 2014 Feb; 34(1):167-8. PubMed ID: 24346745 [No Abstract] [Full Text] [Related]
10. [Alcohol dependence treatment with naltrexone: safety assessment. Observation study group of alcoholic dependence]. Ochoa Mangado E; Arias Horcajadas F; Torres Hernández MA Actas Esp Psiquiatr; 2000; 28(3):161-8. PubMed ID: 11000698 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder. Elchaar GM; Maisch NM; Augusto LM; Wehring HJ Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648 [TBL] [Abstract][Full Text] [Related]
12. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study. Willemsen-Swinkels SH; Buitelaar JK; van Engeland H Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of undesirable effects during the use of opiate antagonists]. Rust M Klin Anasthesiol Intensivther; 1993; 42():108-16. PubMed ID: 8450619 [No Abstract] [Full Text] [Related]
14. Strategies to maximize the efficacy of naltrexone for alcohol dependence. O'Malley SS NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772 [No Abstract] [Full Text] [Related]
15. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Petrakis IL; Nich C; Ralevski E Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890 [TBL] [Abstract][Full Text] [Related]
16. [Naltrexone--high expectations to low dosages]. Raknes G; Giverhaug T Tidsskr Nor Laegeforen; 2011 May; 131(8):844-6. PubMed ID: 21556092 [No Abstract] [Full Text] [Related]
17. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism]. Poser W; Ehrenreich H Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453 [No Abstract] [Full Text] [Related]
18. Blame the counselling, not the implant. A response to Oliver, Horspool & Keen (2005). Kunøe N; Lobmaier P Addiction; 2005 Jul; 100(7):1027-8; author reply 1028-9. PubMed ID: 15955020 [No Abstract] [Full Text] [Related]
19. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone. Fishman M Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831 [TBL] [Abstract][Full Text] [Related]
20. Naltrexone (vivitrol)--a once-monthly injection for alcoholism. Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283 [No Abstract] [Full Text] [Related] [Next] [New Search]